SELVAS Healthcare, Inc. Logo

SELVAS Healthcare, Inc.

Develops and manufactures medical diagnostic devices and IT assistive technology.

208370 | KO

Overview

Corporate Details

ISIN(s):
KR7208370007
LEI:
Country:
South Korea
Address:
대전광역시 유성구 신성로 155 (신성동), 대전광역시

Description

SELVAS Healthcare, Inc. is a digital healthcare company specializing in the development and manufacturing of medical devices and IT assistive technology. Originally established in 1993 as Jawon Medical, the company expanded its portfolio by merging with HIMS International, a manufacturer of assistive technology for the visually impaired. The company's primary product lines include medical diagnostic devices under the ACCUNIQ brand, such as body composition analyzers and automatic blood pressure monitors used in clinical settings. Through its HIMS brand, it provides Braille information instruments and other assistive solutions. SELVAS Healthcare integrates advanced software and artificial intelligence (AI) data processing technologies with its hardware to deliver innovative healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-13 00:00
분기보고서 (2025.03)
Korean 1.4 MB
2025-03-28 00:00
정기주주총회결과
Korean 21.8 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 582.8 KB
2025-03-19 00:00
감사보고서제출
Korean 25.9 KB
2025-03-13 00:00
주주총회소집공고
Korean 136.3 KB
2025-02-27 00:00
주주총회소집결의
Korean 11.1 KB
2025-02-27 00:00
주주총회집중일개최사유신고
Korean 4.3 KB
2025-02-17 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.0 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.2 MB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.2 MB
2024-05-13 00:00
분기보고서 (2024.03)
Korean 1.2 MB
2024-04-09 00:00
주식등의대량보유상황보고서(약식)
Korean 56.5 KB
2024-03-28 00:00
정기주주총회결과
Korean 20.6 KB

Automate Your Workflow. Get a real-time feed of all SELVAS Healthcare, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SELVAS Healthcare, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SELVAS Healthcare, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acarix Logo
Develops AI-powered acoustic devices for non-invasive diagnosis of coronary artery disease.
Sweden
ACARIX
ACCURAY INC Logo
Develops and sells advanced radiation therapy systems for cancer treatment.
United States of America
ARAY
Develops a non-invasive device to monitor blood sugar by analyzing exhaled breath.
Poland
AME
Agfa-Gevaert NV Logo
Develops imaging systems, IT solutions, and advanced materials for various industries.
Belgium
AGFB
Alcon AG Logo
A medical company specializing in surgical equipment and vision care products.
Switzerland
ALC
Arcoma AB Logo
Develops and produces complete digital radiography (DR) systems and radiology solutions.
Sweden
ARCOMA
ASTERASYS Co., Ltd. Logo
Develops medical aesthetic devices using HIFU, RF, and ultrasonic technologies.
South Korea
450950
Baird Medical Investment Holdings Ltd Logo
Develops and sells minimally invasive microwave ablation devices for tumor treatment.
United States of America
BDMD
Beta Bionics, Inc. Logo
Develops and commercializes automated insulin delivery systems for diabetes management.
United States of America
BBNX
BIO PROTECH INC. Logo
Manufacturer of medical equipment, disposable supplies, and bio-medical sensors.
South Korea
199290

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.